Warning: file_get_contents(http://normativacookie.promo.it/cookiebar/cookiebar.php?l=Previous issues&site=d3d3LmNhbmNlcndvcmxkLm9yZw==) [function.file-get-contents]: failed to open stream: HTTP request failed! HTTP/1.1 400 Bad Request in E:\SITI\CANCERWORLDWEB\2013\inc\header.php on line 85

Previous issues

Issue 50 September - October 2012

Issue 50 September - October 2012 flipbook

» [Editorial] Personalised medicine: a note of caution » [Cover Story] Siddhartha Mukherjee: explaining cancer » [Cutting Edge] We told you so: How the persistence of immunotherapy researchers is finally paying off » [Cross Talk] Futile care: Why does it happen, how can we avoid it? » [Best Cancer Reporter Award] In the jungle of the miracle healers » [e-Grand Round] How exposure to a mother's cancer treatment during pregnancy impacts on the child » [Spotlight on...] How bad news can be good news for cancer services » [Impact Factor] For localised prostate cancer, does technology equal progress? » [Impact Factor] Gemtuzumab ozogamicin in acute myeloid leukaemia » [Newsround] Newsround » [My World] My World

Issue 49 July - August 2012

Issue 49 July - August 2012 flipbook

» [Editorial] Winning or losing? ESO asks the experts » [Systems & Services] Patients pay a price for spending cuts » [Cover Story] Mary Gospodarowicz: Just do it » [e-Grand Round] New accomplishments in breast cancer chemoprevention » [Masterpiece] Breaking Boundaries » [Patient Voice] If you could see it through my eyes... » [Impact Factor] Salvage chemotherapy in gastric cancer – more than a straw? » [Impact Factor] Manufacturer sponsorship bias in economic analyses matters » [Newsround] Newsround

Issue 48 May - June 2012

Issue 48 May - June 2012 flipbook

» [Editorial] Framing the argument over futile care » [Cover Story] Mahasti Saghatchian: pioneering a quality mark for Europe's cancer centres » [e-Grand Round] Recent trials in osteosarcoma and their implications for future studies » [Cutting Edge] Can the Reverend Bayes help deliver proven therapies for patients with rare cancers? » [Spotlight on...] Fixing the holes in the opioid supply lines » [Systems & Services] Prostate cancer units: it's about options and quality » [Impact Factor] Localised non-bulky Hodgkin lymphoma - future questions » [Impact Factor] First-line bevacizumab for ovarian cancer - new standard of care? » [Newsround] Newsround

Issue 47 March - April 2012

Issue 47 March - April 2012 flipbook

» [Editorial] Join the battle for biomedical research » [Cover Story] John Crown: Move aside bureaucrats and let us take a lead » [Cutting Edge] International guidelines offer hope of speeding up progress in advanced breast cancer » [e-Grand Round] Endotherapy for Barrett's oesophagus with early neoplasia » [Best Cancer Reporter Award] Living with the timebomb of a childhood cancer » [Spotlight on...] A world-class centre arises from the French ground-zero » [Systems & Services] How are we doing? » [Impact Factor] The importance of local control in pancreatic cancer » [Impact Factor] Time for another rethink on prostate cancer screening » [Newsround] Newsround

Issue 46 January - February 2012

Issue 46 January - February 2012

» [Editorial] Aspirin for cancer prevention: why wait? » [Cover Story] Stein Kaasa: Let me show you what integrated palliative care can do » [e-Grand Round] Optimising dose-dense regimens for early breast cancer » [Cutting Edge] Picture this: The new imaging techniques that can help doctors select the right treatment at the right time » [Best Cancer Reporter Award] Is hope worth any price? » [Masterpiece] Still waiting for the world to catch up » [Systems & Services] After the treatment's over... » [Impact Factor] The silent minority - unpublished data on cancer care » [Impact Factor] Hodgkin lymphoma - absence of evidence not evidence of absence! » [Newsround] Newsround

Issue 45 November - December 2011

Issue 45 November - December 2011

» [Editorial] To cut or not to cut? Why surgeons don't have all the answers » [Cover Story] Luzia Travado: improving outcomes for patients by attending to their distress » [e-Grand Round] Prognostic and predictive markers in colorectal cancer: implications for clinical management » [Best Cancer Reporter Award] Hope for me, and for others who come after: Victoria Lambert's award-winning article explores the impact of a new network of early trial centres » [Masterpiece] Redefining the role of pathology: how Giuseppe Viale embraced the new responsibilities of the molecular era » [Systems & Services] Taking the first step on the road to cancer control » [Impact Factor] An important piece of the localised prostate cancer puzzle? » [Impact Factor] Front-line therapy in lung cancer with mutations in EGFR » [Newsround] Newsround

Issue 44 September - October 2011

Issue 44 September - October 2011

» [Editorial] Securing quality cancer care: Governments must step up to the plate » [Cover Story] Julio Celis: bridging science and politics » [e-Grand Round] State-of-the-art treatment for advanced melanoma » [Best Cancer Reporter Award] The future of cancer, as told through the story of Renee » [Masterclass] The ESO Masterclass: where those most eager to learn meet those most willing to teach » [Masterpiece] Spread the Word » [Spotlight on...] Thirty years on, ESTRO remains focused on its vision for a cure » [Systems & Services] A minimum acceptable standard of care for every patient » [Impact Factor] Denosumab - a new option for solid tumours metastatic to bone » [Impact Factor] Perioperative therapy improves gastro-oesophageal cancer survival » [Newsround] Newsround

Issue 43 July - August 2011

Issue 43 July - August 2011

» [Editorial] Patients need information. Is that clear? » [Cover Story] Peter Naredi: a ‘can do' leader for Europe's cancer surgeons » [e-Grand Round] Decision making in the treatment of gliomas » [Cutting Edge] Beyond Survival--what should new cancer drugs have to prove and how? » [Masterpiece] For the love of the job » [Spotlight on...] Unshackling progress in the care of childhood cancers » [Focus] Think yourself better » [Impact Factor] Rituximab for follicular lymphoma: maintaining an open mind » [Impact Factor] ASTER--another flow in the diagnostic field of lung cancer? » [Newsround] Newsround

Issue 42 May - June 2011

Issue 42 May - June 2011

» [Editorial] Adapting services to the age of oral therapies » [Cover Story] Jean-Yves Blay: integrating translational and clinical research » [e-Grand Round] New approaches to treating gastro-oesophageal cancer » [Cutting Edge] International biobanking regulations: the promise and the pitfalls » [Masterpiece] The secret behind a successful clinical trial » [Systems & Services] Cutting unnecessary deaths from cervical cancer » [Impact Factor] Hypoxia modification with radiotherapy for bladder cancer » [Impact Factor] An 18-gene signature (ColoPrint) for colon cancer prognosis » [Newsround] Newsround

Issue 41 March - April 2011

Issue 41 March - April 2011

» [Editorial] A million voices against cancer » [Cover Story] Ruth Ladenstein: raising standards of care for our young patients » [e-Grand Round] Treatment of triple negative breast cancer » [Cutting Edge] Reading the signs » [Best Cancer Reporter Award] Think before you ruin your patient's chance of parenthood » [Masterpiece] A simple doctor's quest to improve on today's treatments » [Spotlight on...] Where are the consensus guidelines for women with metastatic disease? » [Systems & Services] An advanced oncology degree for busy specialists across the globe » [Impact Factor] Failure of bevacizumab in early-stage colon cancer » [Impact Factor] Ultra-targeted accelerated partial breast irradiation using TARGIT – a cautionary note » [Newsround] NEWSROUND

Pagina 3 di 7       1 | 2 | 3 | 4 | 5 | 6 | 7